Erythromycin C reduced derivatives CAS CATO-C4X-100169
| CAS No. | CATO-C4X-100169 |
| Molecular Formula | C36H68N2O12 |
| Molecular Weight | 720.93 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
CATO manufactures Erythromycin C reduced derivatives under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
CATO supplies Erythromycin C reduced derivatives (CAS CATO-C4X-100169), a certified reference material (molecular formula C36H68N2O12, MW 720.93 g/mol) for analytical method development and quality control.
The molecular framework of Erythromycin C reduced derivatives (C36H68N2O12) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C36H68N2O12 |
| Molecular Weight | 720.93 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 4.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 2 |
Related Erythromycin Standards
- Erythromycin thiocyanate impurity B reduced derivative (CAS CATO-C4X-100166)
- Erythromycin EP Impurity B (CAS 992-62-1)
- Erythromycin C (CAS 1675-02-1)
- Erythromycin 4’- (CAS 200802-92-2)
- Erythromycin B (CAS 527-75-3)
- Erythromycin C rearranged derivatives (CAS CATO-C4X-100171)
- Erythromycin thiocyanate impurity B rearranged derivative (CAS CATO-C4X-100174)
- Erythromycin EP Impurity E (CAS 33396-29-1)
Recommended Standards
- Azithromycin Impurity 34 (CAS CATO-C4X-100334)
- Andamertinib Impurity 1 (CAS CATO-C4X-35351)
- Azithromycin EP Impurity E (CAS 612069-27-9)
- 1,3-Dihydroxy-2,4-bis[5-(4-morpholinyl)-3,4-diphenyl-2-thienyl]-Cyclobutenediylium bis(inner salt) (CAS 137020-23-6)
- Cyclohexyl 4-(5-(2-chloro-4-nitrophenyl)furan-2-carboxamido)benzoate (CAS 7061-86-1)
- 2-Chloro-5-(chloromethyl)thiophene (CAS 23784-96-5)
- 1-(2,3-Dihydro-1h-inden-5-yl)propan-2-one (CAS 1344334-29-7)
- GLP-1(7-37) (CAS 106612-94-6)
- 1-Benzoyl-1H-indole-3-carbonitrile (CAS 90539-80-3)
- tert-Butyl 1,4-phenylenedicarbamate (CAS 121680-23-7)
- 5,7-Dichloro-1-oxoisochroman-3-carboxylic acid (CAS 1594701-00-4)
- 2-(2-Methoxy-4,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS 1134082-52-2)
- 4-Propionylbenzoic acid (CAS 4219-55-0)
- Insulin Degludec Impurity 3 (CAS CATO-C4X-21573)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com